Pre-IPO Access
How to invest before public listing in biotech.
866 tracked pre-IPO offerings →5 tracked longevity and biotech offerings →
Largest SEC filers in this category
Ranked by the total reported sold on the latest Form D or Regulation A notice. Each page carries the filing record, the related persons and what to check; AltStreet gives no verdict on an issuer.
- Decheng Capital Global Life Sciences Fund V, L.P.2025 · $452M · 42 investors
- Fund FG-BLU, a series of Forge Investments LLC2026 · $397M · 148 investors · Forge Global
- Fund FG-LRN, a series of Forge Investments, LLC2026 · $380M · 85 investors · Forge Global
- ASP (Feeder) Global Secondary Fund 8 LP2025 · $258M · 28 investors
- Fund FG-ANO, a series of Forge Investments LLC2026 · $222M · 102 investors · Forge Global
- Fund FG-LHU, a series of Forge Investments, LLC2026 · $140M · 53 investors · Forge Global
- Fund FG-MBW, a series of Forge Investments LLC2026 · $139M · 99 investors · Forge Global
- Felicitas Liquidity Solutions Fund (Offshore), LP2026 · $108M · 10 investors
- Star Mountain U.S. Lower Middle-Market Secondary Fund III (Offshore), LP2026 · $96.9M · 8 investors
- Fund FG-ONJ, a series of Forge Investments, LLC2020 · $92.6M · 118 investors · Forge Global
- Special Situations Life Sciences Fund LP2025 · $75.3M · 112 investors
- Fund FG-SMP, a series of Forge Investments LLC2026 · $66.4M · 53 investors · Forge Global
- Fund EQ-DGO, a series of Forge Investments LLC2026 · $66.3M · 81 investors · Forge Global
- Fund FG-NAS, a series of Forge Investments LLC2026 · $66.1M · 72 investors · Forge Global
- EquityZen Growth Technology Fund LLC - Series 23002026 · $66.0M · 402 investors · EquityZen
- Sky Life Sciences Fund, LP2026 · $62.1M · 10 investors
- Felicitas Liquidity Solutions Fund, LP2026 · $57.4M · 35 investors
- CCA Longevity Fund III (US), LLC2023 · $54.6M · 51 investors
- Hiive SpaceX Opp Fund-02, LLC2026 · $54.5M · 541 investors · Clarity
- CCA LONGEVITY FUND IV (US II), LLC2023 · $48.2M · 90 investors
Latest Research & Analysis
View All
The Longevity Biotech Investment Guide: How to Invest in the $600B Healthspan Economy
From Altos Labs' $3B funding to senolytics reaching $25B by 2030: your complete guide to early-stage longevity biotech, Pre-IPO valuations, and anti-aging VC.
Longevity Investments 2026: Where Longevity Biotech Funding Is Going
Longevity biotech funding in 2026: capital doubled to $8.5B in 2024 while deal counts fell. Who funds geroscience, which rounds closed, how investors get in.
Related Investment Opportunities in Longevity & Biotech Pre-IPO
Get Expert Analysis on Pre-IPO Access
Subscribe to receive detailed platform reviews, performance analysis, and investment strategies for pre-ipo access and other alternative assets.
Subscribe to Newsletter